logo

For the Inventor, By the Inventor

Groton, CT, United States of America

Katherine E Brighty

USPTO Granted Patents = 15

Average Co-Inventor Count = 1.7

ph-index = 6

Forward Citations = 108(Granted Patents)


Company Filing History:

goldMedal15 out of 4,455 
 
Pfizer Corporation
 patents

Years Active: 1987-2010

Loading Chart...
15 patents (USPTO):Explore Patents
1. 7795244 - Penem prodrugs (2010-09-14),
2. 7795243 - Penem prodrugs (2010-09-14),
3. 6562792 - Hygromycin derivatives (2003-05-13),
4. 6313100 - Hygromycin derivatives (2001-11-06),
5. 6300316 - C-4 substituted macrolide antibiotics (2001-10-09),
6. 5475116 - Aza bicyclo[3,1,0]hexane intermediates useful in the synthesis of (1995-12-12),
7. 5391763 - 3-aza-bicyclo[3.1.0]hexanes which are intermediates for anti-bacterial (1995-02-21),
8. 5266569 - Azatricyclo carboxylic acids useful as anti-bacterial agents (1993-11-30),
9. 5229396 - Anti-bacterial azabicyclo quinolone carboxylic acids (1993-07-20),
10. 5214051 - Thiazolyl and oxazolyl[5,4-c]piperidyl-substituted quinolone-carboxylic (1993-05-25),
11. 5164402 - Azabicyclo quinolone and naphthyridinone carboxylic acids (1992-11-17),
12. 5037834 - Heterocycylic-substituted quinoline-carboxylic acids (1991-08-06),
13. 4782146 - Process for the synthesis of penems (1988-11-01),
14. 4782145 - Process for penem derivatives (1988-11-01),
15. 4695626 - 1-aza-4,5-dithiabicyclo [4.2.0] oct-2-en-8-one-2 carboxylate esters (1987-09-22),

Title: Katherine E Brighty: Innovator in Pharmaceutical Science

Introduction

Katherine E Brighty is a prominent inventor based in Groton, CT (US). She has made significant contributions to the field of pharmaceutical science, particularly in the development of prodrugs. With a total of 15 patents to her name, her work has had a substantial impact on the treatment and prevention of infections in mammals, including humans.

Latest Patents

Among her latest patents is the innovative work on Penem prodrugs, which are orally bioavailable prodrugs of sulopenem. This invention includes solvates and hydrates thereof, along with their preparation, formulation, and use to treat and prevent infections in mammals. The abstract of this patent emphasizes that it is not limiting to the invention, showcasing the potential for further advancements in this area.

Career Highlights

Katherine has built a successful career at Pfizer Corporation, where she has been instrumental in advancing pharmaceutical research and development. Her expertise in creating effective drug formulations has positioned her as a key player in the industry.

Collaborations

Throughout her career, Katherine has collaborated with notable colleagues, including Paul R McGuirk and John Adams Lowe, III. These partnerships have fostered innovation and have contributed to the success of her projects.

Conclusion

Katherine E Brighty is a remarkable inventor whose work in pharmaceutical science continues to influence the field. Her dedication to developing effective treatments demonstrates her commitment to improving health outcomes for individuals worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…